Outcomes of endovascular treatment versus bypass surgery for critical limb ischemia in patients with thromboangiitis obliterans.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      We aimed to compare the clinical outcomes between endovascular treatment and inframalleolar bypass surgery for critical limb ischemia (CLI) in patients with thromboangiitis obliterans (TAO) and to assess the role of bypass surgery in the era of innovative endovascular treatment. Between January 2007 and December 2017, a total of 33 consecutive patients with the diagnosis of TAO presenting with CLI who underwent endovascular treatment (endovascular group, n = 22) or bypass surgery to the pedal or plantar vessels (bypass group, n = 11) were included and analyzed retrospectively. The primary endpoint was defined as a major amputation of the index limb, and the secondary endpoint was defined as graft occlusion, regardless of the number of subsequent procedures. In the bypass group, six patients (55%) had undergone previous failed endovascular procedures and/or arterial bypass surgery to the index limb before inframalleolar bypass, and two patients (18%) received microvascular flap reconstruction after bypass surgery. During the median follow-up period of 32 months (range 1-115 months), there were no significant differences in primary and secondary endpoints between the two groups although the bypass group had a higher Rutherford class than the endovascular group. Kaplan-Meier survival analysis showed that there were similar limb salvage (P = 0.95) and graft patency rates (P = 0.39). In conclusion, endovascular treatment is a valid strategy leading to an acceptable limb salvage rate for TAO patients, and surgical bypass to distal target vessels could play a vital role in cases of previous failed endovascular treatment or extensive soft tissue loss of the foot.
      Competing Interests: The authors have declared that no competing interests exist.
    • References:
      J Vasc Surg. 2007 Jan;45 Suppl S:S5-67. (PMID: 17223489)
      Eur J Vasc Endovasc Surg. 2016 Dec;52(6):815-822. (PMID: 27707633)
      Br J Plast Surg. 2001 Jan;54(1):76-9. (PMID: 11121326)
      Vasa. 2017 Jul;46(4):304-309. (PMID: 28271745)
      Eur J Vasc Endovasc Surg. 1997 Feb;13(2):186-92. (PMID: 9091153)
      Eur J Vasc Endovasc Surg. 2017 Mar;53(3):387-402. (PMID: 28027892)
      J Vasc Surg. 2014 Jun;59(6):1583-7. (PMID: 24418639)
      J Vasc Surg. 2004 Jan;39(1):176-80. (PMID: 14718836)
      Ann Vasc Surg. 2012 Apr;26(3):422.e5-8. (PMID: 22284776)
      Eur J Vasc Endovasc Surg. 2002 Oct;24(4):309-13. (PMID: 12323173)
      Eur J Vasc Endovasc Surg. 2005 Jan;29(1):47-51. (PMID: 15570271)
      Int J Cardiol. 1998 Oct 1;66 Suppl 1:S243-5; discussion S247. (PMID: 9951826)
      Eur J Vasc Endovasc Surg. 2015 Aug;50(2):223-30. (PMID: 26001322)
      Ann Vasc Surg. 2016 Jan;30:263-9. (PMID: 26370744)
      Circulation. 2010 Apr 27;121(16):1858-61. (PMID: 20421527)
      Lancet. 1999 Dec 4;354(9194):1962-5. (PMID: 10622299)
      Eur J Vasc Endovasc Surg. 2006 May;31(5):493-9. (PMID: 16488164)
      J Vasc Surg. 2016 Jul;64(1):e1-e21. (PMID: 27345516)
      Eur J Vasc Endovasc Surg. 2009 Mar;37(3):336-42. (PMID: 19112033)
      J Vasc Surg. 2017 Oct;66(4):1133-1142.e1. (PMID: 28697938)
      Surg Today. 2002;32(12):1042-7. (PMID: 12541020)
      Surg Today. 2015 Apr;45(4):466-70. (PMID: 24845736)
      J Foot Ankle Surg. 2014 May-Jun;53(3):312-5. (PMID: 24613785)
      J Vasc Surg. 2003 Feb;37(2):307-15. (PMID: 12563200)
      Br J Surg. 2004 Feb;91(2):159-67. (PMID: 14760662)
    • Publication Date:
      Date Created: 20181010 Date Completed: 20190320 Latest Revision: 20221207
    • Publication Date:
      20240829
    • Accession Number:
      PMC6177182
    • Accession Number:
      10.1371/journal.pone.0205305
    • Accession Number:
      30300407